ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: CML is characterized by the presence of translocation-creating oncoprotein BCR-ABL1, and the development of this disease consists of three phases, namely, the chronic phase (CP), accelerated phase (AP), and blast crisis phase (BP) [67].